Protein-coding gene in the species Homo sapiens
Chloride channel 7 alpha subunit also known as H+ /Cl− exchange transporter 7 is aprotein that in humans is encoded by the CLCN7gene .[ 5] melanocytic cells this gene is regulated by theMicrophthalmia-associated transcription factor .[ 6] [ 7]
Clinical significance [ edit ] Mutations in the CLCN7 gene have been reported to be associated with autosomal dominantosteopetrosis type II, a rare disease of bones.[ 8]
^a b c GRCh38: Ensembl release 89: ENSG00000103249 –Ensembl , May 2017^a b c GRCm38: Ensembl release 89: ENSMUSG00000036636 –Ensembl , May 2017^ "Human PubMed Reference:" .National Center for Biotechnology Information, U.S. National Library of Medicine .^ "Mouse PubMed Reference:" .National Center for Biotechnology Information, U.S. National Library of Medicine .^ "Entrez Gene: CLCN7 chloride channel 7" .^ Meadows NA, Sharma SM, Faulkner GJ, Ostrowski MC, Hume DA, Cassady AI (2007)."The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor" .J. Biol. Chem .282 (3):1891– 904.doi :10.1074/jbc.M608572200 PMID 17105730 . ^ Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (2008)."Novel MITF targets identified using a two-step DNA microarray strategy" .Pigment Cell Melanoma Res .21 (6):665– 76.doi :10.1111/j.1755-148X.2008.00505.x PMID 19067971 .S2CID 24698373 . ^ Coudert AE, Del Fattore A, Baulard C, Olaso R, Schiltz C, Collet C, Teti A, de Vernejoul MC (2014)."Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology" (PDF) .Lab. Invest .94 (3):275– 85.doi :10.1038/labinvest.2013.140 PMID 24336069 .S2CID 5097233 . Brandt S, Jentsch TJ (1996). "ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family".FEBS Lett .377 (1):15– 20.doi :10.1016/0014-5793(95)01298-2 .PMID 8543009 .S2CID 717696 . Héon E, Piguet B, Munier F, et al. (1996). "Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21".Arch. Ophthalmol .114 (2):193– 8.doi :10.1001/archopht.1996.01100130187014 .PMID 8573024 . Lennon G, Auffray C, Polymeropoulos M, Soares MB (1996)."The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression" .Genomics .33 (1):151– 2.doi :10.1006/geno.1996.0177 PMID 8617505 . Eggermont J (1998). "The exon-intron architecture of human chloride channel genes is not conserved".Biochim. Biophys. Acta .1397 (2):156– 60.doi :10.1016/s0167-4781(98)00014-1 .PMID 9565675 . White KE, Koller DL, Takacs I, et al. (1999)."Locus heterogeneity of autosomal dominant osteopetrosis (ADO)" .J. Clin. Endocrinol. Metab .84 (3):1047– 51.doi :10.1210/jcem.84.3.5578 PMID 10084593 .S2CID 46056019 . Daniels RJ, Peden JF, Lloyd C, et al. (2001)."Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16" .Hum. Mol. Genet .10 (4):339– 52.doi :10.1093/hmg/10.4.339 PMID 11157797 . Kornak U, Kasper D, Bösl MR, et al. (2001)."Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man" .Cell .104 (2):205– 15.doi :10.1016/S0092-8674(01)00206-9 PMID 11207362 . Cleiren E, Bénichou O, Van Hul E, et al. (2002). "Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene".Hum. Mol. Genet .10 (25):2861– 7.doi :10.1093/hmg/10.25.2861 .PMID 11741829 . Harada K, Toyooka S, Maitra A, et al. (2002). "Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines".Oncogene .21 (27):4345– 9.doi :10.1038/sj.onc.1205446 .PMID 12082624 .S2CID 26627369 . Strausberg RL, Feingold EA, Grouse LH, et al. (2003)."Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences" .Proc. Natl. Acad. Sci. U.S.A .99 (26):16899– 903.Bibcode :2002PNAS...9916899M .doi :10.1073/pnas.242603899 PMC 139241 PMID 12477932 . Campos-Xavier AB, Saraiva JM, Ribeiro LM, et al. (2003). "Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis".Hum. Genet .112 (2):186– 9.doi :10.1007/s00439-002-0861-9 .PMID 12522560 .S2CID 33010093 . Waguespack SG, Koller DL, White KE, et al. (2004). "Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II".J. Bone Miner. Res .18 (8):1513– 8.doi :10.1359/jbmr.2003.18.8.1513 .PMID 12929941 .S2CID 23907779 . Frattini A, Pangrazio A, Susani L, et al. (2004)."Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis" .J. Bone Miner. Res .18 (10):1740– 7.doi :10.1359/jbmr.2003.18.10.1740 PMID 14584882 .S2CID 20966489 . Ota T, Suzuki Y, Nishikawa T, et al. (2004)."Complete sequencing and characterization of 21,243 full-length human cDNAs" .Nat. Genet .36 (1):40– 5.doi :10.1038/ng1285 PMID 14702039 . Henriksen K, Gram J, Schaller S, et al. (2004)."Characterization of Osteoclasts from Patients Harboring a G215R Mutation in ClC-7 Causing Autosomal Dominant Osteopetrosis Type II" .Am. J. Pathol .164 (5):1537– 45.doi :10.1016/S0002-9440(10)63712-1 .PMC 1615650 PMID 15111300 . Gerhard DS, Wagner L, Feingold EA, et al. (2004)."The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)" .Genome Res .14 (10B):2121– 7.doi :10.1101/gr.2596504 .PMC 528928 PMID 15489334 . Köttgen M, Benzing T, Simmen T, et al. (2005)."Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation" .EMBO J .24 (4):705– 16.doi :10.1038/sj.emboj.7600566 .PMC 549624 PMID 15692563 . Pettersson U, Albagha OM, Mirolo M, et al. (2006)."Polymorphisms of the CLCN7 gene are associated with BMD in women" .J. Bone Miner. Res .20 (11):1960– 7.doi :10.1359/JBMR.050717 PMID 16234969 .S2CID 22530335 . Kornak U, Ostertag A, Branger S, et al. (2006). "Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II".J. Clin. Endocrinol. Metab .91 (3):995– 1000.doi :10.1210/jc.2005-2017 .PMID 16368748 .S2CID 25948191 . Olsen JV, Blagoev B, Gnad F, et al. (2006)."Global, in vivo, and site-specific phosphorylation dynamics in signaling networks" .Cell .127 (3):635– 48.doi :10.1016/j.cell.2006.09.026 PMID 17081983 .S2CID 7827573 . This article incorporates text from theUnited States National Library of Medicine , which is in thepublic domain .
